Single-Dose Intramuscular Toxicity Test Using No-Pain Pharmacopuncture in Sprague–Dawley Rats
1
조회
0
다운로드
6
인용
0
참고문헌
키워드
초록
Objectives: This study aimed to evaluate the potential toxicity of a recently developed and clinically used No-Pain pharmacopuncture (NPP) solution. We also assessed the lethal dose of the NPP agent following a single intramuscular injection in Sprague-Dawley (SD) rats. Methods: Animals were divided into two groups: the NPP test material group and the normal saline control group. A single intramuscular injection of the NPP agent (1.0 mL/ animal) was administered to rats of the NPP test material group. The control group rats received the same volume of normal saline. Both female and male rats were included in each group. All rats were monitored for clinical signs and body weight changes for 14 days after administration of the test substance or saline. At the end of the observation period, a gross necropsy was conducted and localized tolerance at the injection site was analyzed. Results: No mortality was observed in the NPP test material and control groups. Moreover, no test substance-related effects were observed on clinical signs, body weight, necropsy findings, and localized tolerance at the injection site. Conclusion: The approximate lethal dose of the NPP agent is greater than 1.0 mL/animal under the conditions used in this study. Additional toxicity evaluations and clinical studies are needed to confirm the safety of NPP use in clinical practice.
Abstract
Objectives: This study aimed to evaluate the potential toxicity of a recently developed and clinically used No-Pain pharmacopuncture (NPP) solution. We also assessed the lethal dose of the NPP agent following a single intramuscular injection in Sprague-Dawley (SD) rats. Methods: Animals were divided into two groups: the NPP test material group and the normal saline control group. A single intramuscular injection of the NPP agent (1.0 mL/ animal) was administered to rats of the NPP test material group. The control group rats received the same volume of normal saline. Both female and male rats were included in each group. All rats were monitored for clinical signs and body weight changes for 14 days after administration of the test substance or saline. At the end of the observation period, a gross necropsy was conducted and localized tolerance at the injection site was analyzed. Results: No mortality was observed in the NPP test material and control groups. Moreover, no test substance-related effects were observed on clinical signs, body weight, necropsy findings, and localized tolerance at the injection site. Conclusion: The approximate lethal dose of the NPP agent is greater than 1.0 mL/animal under the conditions used in this study. Additional toxicity evaluations and clinical studies are needed to confirm the safety of NPP use in clinical practice.
참고문헌 (34)
- Ardalan MR, "Is the safety of herbal medicines for kidneys under question?", J Nephropharmacol, 2(2), pp.11~12 (2013)
- Ji Hye Hwang, "Genotoxicity Evaluation of Capsaicin-Containing (CP) Pharmacopuncture, in an In Vivo Micronucleus Test", Journal of Pharmacopuncture, 23(4), pp.237~246 (2020), 대한약침학회
- "(Herbal Medicine) Regulation on Approval and Notification of Herbal (crude) Medicinal Preparations, Etc" (2022)[URL]
- Wiebrecht A, "Letter : Herbal hepatotoxicity--an update on traditional Chinese medicine preparations", Aliment Pharmacol Ther, 40(6), pp.737~738 (2014)
- Kim EJ, "Evidence-based toxicity evaluation and scheduling of Chinese herbal medicines", J Ethnopharmacol, 146(1), pp.40~61 (2013)
- Zhou J, "Potential genotoxicity of traditional chinese medicinal plants and phytochemicals : an overview", Phytother Res, 27(12), pp.1745~1755 (2013)
- "Good Laboratory Practice (GLP)" (2017)[URL]
- "Partial Amendment Official Announcement about Toxicity Test for Drug" (2015)[URL]
- Lee MY, "Genotoxicity evaluation of Guibi-Tang extract using an in vitro bacterial reverse mutation assay, chromosome aberration assay, and in vivo micronucleus test", BMC Complement Altern Med, 14, pp.215~ (2014)
- Jeong Jin-Ho, "A Study on the Significance of Acupuncture and Pharmacopuncture Therapy for Cold Accumulation Through a Literature Review on the Historical Development Process in Cold Accumulation Treatment", Journal of Acupuncture Research, 39(4), pp.267~274 (2022), 대한침구의학회[DOI]
- Korean Acupuncture and Moxibustion Society, "Acupuncture medicine" (2020), Hanmi Medical Publishing Co
- 성수현, "Current Status of Management on Pharmacopuncture in Korea through Introduction of an Accreditation System", Journal of Pharmacopuncture, 22(2), pp.75~82 (2019), 대한약침학회[DOI]
- Park J, "Pharmacopuncture in Korea: a systematic review and meta-analysis of randomized controlled trials", Evid Based Complement Alternat Med, 2016, pp.4683121~ (2016)
- Park JE, "Usage status and satisfaction with pharmacopuncture in Korea: a survey among Korean medicine doctors", Eur J Integr Med, 27, pp.121~130 (2019)
- Hwang Ji Hye, "Single-Dose Intramuscular Toxicity Study of SU-Eohyeol Pharmacopuncture in Rats", Journal of Pharmacopuncture, 25(3), pp.268~275 (2022), 대한약침학회[DOI]
- Park JE, "A survey on Korean medicine doctor’s use of Herbal Acupuncture and recognition of its national health insurance coverage", master, pp.2018
- Tian B, "Advances in phytochemical and modern pharmacological research of Rhizoma Corydalis", Pharm Biol, 58(1), pp.265~275 (2020)
- Li B, "A systems biology approach to understanding the mechanisms of action of Chinese herbs for treatment of cardiovascular disease", Int J Mol Sci, 13(10), pp.13501~13520 (2012)
- Takao Y, "Shakuyaku-kanzo-to(Shao-Yao-Gan-Cao-Tang)as treatment of painful muscle cramps in patients with lumbar spinal stenosis and its minimum effective dose", Kobe J Med Sci, 61(5), pp.E132~E137 (2015)
- Kim M, "Chaenomelis fructus inhibits osteoclast differentiation by suppressing NFATc1 expression and prevents ovariectomy-induced osteoporosis", BMC Complement Med Ther, 20(1), pp.35~ (2020)
- Herbology Editorial Committee of Korean Medicine, "Herbology" (2004), Younglimsa
- Wang L, "The antinociceptive properties of the Corydalis yanhusuo extract", PLoS One, 11(9), pp.e0162875~ (2016)
- Chinese Pharmacopoeia Commission, "Pharmacopoeia of the People’s Republic of China. Vol. 1" (2015), China Medical Science Press
- Ahn CJ, "The analgesic effect of aqua-acupuncture with Corydalis Tuber, Olibanum Mastix & Myrrha", J Korean Acupunct Moxib Med Soc, 11(1), pp.145~158 (1994)
- Ahn HS, "Effects of Corydalis Tuber Aquaacupuncture on the pain and convulsion in mice and gastric ulcer in rats", J Korean Acupunct Moxib Med Soc, 11(1), pp.99~111 (1994)
- Choi WY, "Modulation of inflammatory mediators by corydalis tuber in LPS-stimulated Raw264. 7 cells and its inhibitory effects on carrageenan-stimulated paw edema in rats", Orient Pharm Exp Med, 14(4), pp.319~328 (2014)
- Yoon SJ, "Effect of Corydalidis Tuber. Carthami Flos. Paeoniae Radix Rubra on anti-inflamation and function of the liver at arthritis rats", Korean J Orient Physiol Pathol, 19(2), pp.475~480 (2005)
- 강준혁, "약침의 연구 동향에 대한 분석 -항염, 진통, 비만 및 안전성에 관한 연구를 중심으로-", 대한한의학회지, 28(2), pp.93~113 (2007), 대한한의학회
- 김현지, "丁公藤玄胡索藥鍼이 류마티스 관절염 생쥐 모델에 미치는 영향", Journal of Acupuncture Research, 33(2), pp.21~34 (2016), 대한침구의학회
- 윤정원, "중성어혈약침 치료에 대한 임상논문 고찰 - 국내학술지를 중심으로", 한방재활의학과학회지, 27(4), pp.75~84 (2017), 한방재활의학과학회
- Chen Q, "Effects and mechanisms of glucosides of chaenomeles speciosa on collagen-induced arthritis in rats", Int Immunopharmacol, 3(4), pp.593~608 (2003)
- 권강, "The Experimental Study on Chaenomelis Fructus(木瓜) in Case of the Arthritis Induced by Injecting Freund's Complete Adjuvant", Journal of Pharmacopuncture, 6(2), pp.29~43 (2003), 대한약침학회[DOI]
- Hyodo T, "Immediate effect of Shakuyaku-kanzo-to on muscle cramp in hemodialysis patients", Nephron Clin Pract, 104(1), pp.c28~c32 (2006)
- Blyton F, "Non-drug therapies for lower limb muscle cramps", Cochrane Database Syst Rev, 1(1), pp.CD008496~ (2012)